Clinical Trials Browser

Phase NA × Unknown × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Clear all

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04663100 2023-12-04

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

LymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Multiple Chronic Conditions, Leukemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT05080829 2021-10-18

Myeloid Mutations Register in R/R CML

Phase NA Unknown

29 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT03062436 2019-07-23

To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission

Phase NA Unknown

27 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT01564836 2014-01-13

Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib

Phase NA Unknown

50 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00538447 2011-12-13

Prospective Database for Chronic Myelogenous Leukemia

Phase NA Unknown

2,000 enrolled

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical Trials

EPIK

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

Myeloid Mutations Register in R/R CML

To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission

Discontinuation Study of Imatinib in Adult CP CML Patients Who Have a Complete Molecular Response to Imatinib

Prospective Database for Chronic Myelogenous Leukemia